Clinical Trials Directory

Trials / Recruiting

RecruitingNCT05847634

Depth of Sedation and Its Impact on Cerebrovascular Reactivity in Acute Respiratory Distress Syndrome: a Pilot Analysis

Status
Recruiting
Phase
Study type
Observational
Enrollment
40 (estimated)
Sponsor
University of Manitoba · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Investigation of the feasibility of monitoring processed transcutaneous electroencephalography (EEG), a method of interpreting brain activity, and near-infrared spectroscopy (NIRS), a method of determining levels of tissue oxygenation (StO2) in the brain, for patients with acute respiratory distress syndrome (ARDS) in the ICU.

Detailed description

The aim of this study is to determine the feasibility of using Masimo SedLine processed EEG monitoring and Masimo O3 NIRS to monitor optimal depth of sedation for patients with ARDS in the ICU. To achieve this, non-invasive devices will be applied to the participant to measure processed EEG signal and StO2. Cerebrovascular reactivity will be determined using the following two values: 1. SEDopt: The optimal depth of sedation that minimizes correlation between StO2 and processed EEG monitoring. 2. MAPopt: The optimal blood pressure that minimizes correlation between StO2 and MAP. Demographic information (age, sex, height, weight), past medical history, etiology of ARDS, Disease severity, routine bloodwork, and dose of sedation will also be documented.

Conditions

Interventions

TypeNameDescription
DEVICEMasimo O3 NIRS cerebral oximetry and SedLine processed EEGNon-invasive neuromonitoring device for observational study

Timeline

Start date
2024-11-25
Primary completion
2026-01-01
Completion
2026-01-01
First posted
2023-05-06
Last updated
2024-12-06

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT05847634. Inclusion in this directory is not an endorsement.